Kashiv BioSciences and CRISTÁLIA Sign Licensing and Supply Deal for Omalizumab Biosimilar in Latin America Read more
Scipher Medicine and Maxymune Therapeutics Partner to Speed Autoimmune and Inflammatory Disease Target Discovery Read more
FDA Approves INLEXZO (Gemcitabine Intravesical System), Poised to Transform Treatment of Certain Bladder Cancers Read more
Teva’s Emrusolmin Receives FDA Fast Track Designation for Multiple System Atrophy Treatment Read more